GLP-1 medications have become some of the most talked about drugs in medicine—but are they really just "skinny shots"?

In this episode of Weight & Measure with Mike and Zach, we sit down with two of the most respected voices in obesity care to separate fact from fiction and explore where obesity treatment is heading next.

Joining us are:

Ted Kyle, RPh, MBA – Founder of ConscienHealth and one of the nation's leading advocates for evidence-based obesity policy and public education.

Katherine Saunders, MD, DABOM – Obesity Medicine physician and nationally recognized expert on GLP-1 medications, emerging obesity therapies, and comprehensive obesity care.

Together, we discuss why GLP-1 medications are changing much more than body weight, how obesity medicine is shifting its focus toward overall health, and why the next generation of therapies—including retatrutide—could reshape obesity treatment once again.

• Why calling GLP-1s "skinny shots" misses the bigger picture.
• How GLP-1 medications are changing healthcare, society, and the conversation around obesity.
• Why obesity is a chronic disease—and why that idea still faces resistance.
• What CKM (Cardiovascular, Kidney, and Metabolic Health) means and why it's becoming a new framework for treating patients.
• The latest research on access to obesity care and what the "secret shopper" study revealed.
• How social media has influenced public understanding of obesity, for better and for worse.
• The science behind glucagon agonists, amylin agonists, and combination therapies.
• Why retatrutide has generated so much excitement—and why experts caution that more weight loss doesn't automatically mean a better medication.
• How GLP-1 medications fit alongside metabolic and bariatric surgery as part of comprehensive, individualized obesity care.
• What today's obesity experts hope we'll understand differently about GLP-1s twenty years from now.

Whether you're living with obesity, taking a GLP-1 medication, considering metabolic and bariatric surgery, following the latest research on retatrutide, or simply trying to better understand obesity as a chronic disease, this conversation provides practical, evidence-based insights grounded in science—not stigma.

• Ted Kyle, RPh, MBA
• Katherine Saunders, MD, DABOM

GLP-1 • GLP-1 medications • Retatrutide • Tirzepatide • Semaglutide • Ozempic • Wegovy • Mounjaro • Zepbound • Obesity Medicine • Obesity Care • Chronic Disease • CKM • Cardiovascular Kidney Metabolic Health • Metabolic and Bariatric Surgery • Weight Loss Medications • Anti-Obesity Medications • Emerging Obesity Therapies • Glucagon Agonists • Amylin Agonists • Comprehensive Obesity Care • Weight Bias • Obesity Advocacy • Patient Advocacy • Evidence-Based Medicine

If you enjoyed this conversation, be sure to subscribe to Weight & Measure on YouTube and follow us on Spotify, Apple Podcasts, and Amazon Music so you never miss future conversations exploring the science of obesity, GLP-1 medications, metabolic and bariatric surgery, and the future of evidence-based obesity care.

More Science. Less Stigma.

What were the biggest conversations coming out of the OAC Your Weight Matters Conference?

In this special episode of Weight & Measure, hosts Mike Donnelly Boylen and Zach Niemiec are joined by an outstanding panel to discuss the most impactful moments from the conference, including the latest conversations in obesity medicine, GLP-1 medications, bariatric surgery, patient advocacy, exercise science, and comprehensive obesity care.

Joining us are:

• Jay Hutchins, Host of the Cheers to This Podcast

• Gianna Beasley, RD, CPT

• Renee Rogers, PhD

• Robyn Pashby, PhD

Together, we discuss:

• Key takeaways from the OAC Your Weight Matters Conference

• The future of obesity medicine and comprehensive obesity care

• The role of GLP-1 medications and other obesity management medications

• Bariatric surgery and long-term obesity treatment

• Exercise, nutrition, and behavior change for people living with obesity

• Patient advocacy and reducing weight stigma

• Why obesity is a chronic disease that deserves evidence-based care

• The latest research and conversations shaping the future of obesity care

Whether you're a person living with obesity, a bariatric patient, obesity medicine clinician, registered dietitian, exercise professional, or healthcare provider, this episode offers practical insights from one of the nation's leading obesity conferences.

Topics Covered:

• Obesity

• Obesity Medicine

• GLP-1 Medications

• Bariatric Surgery

• Metabolic & Bariatric Surgery

• Comprehensive Obesity Care

• Exercise Science

• Nutrition

• Patient Advocacy

• Weight Stigma

• OAC Your Weight Matters Conference

• Obesity Action Coalition (OAC)

• Chronic Disease

• Lifestyle Medicine

• Weight Management

Subscribe to Weight & Measure on Apple Podcasts, Spotify, Amazon Music, or wherever you listen to podcasts for conversations with leading experts in obesity medicine, bariatric surgery, nutrition, advocacy, and metabolic health.

Do You Have Comprehensive Obesity Care? GLP-1s, Obesity Medicine & Bariatric Surgery Explained

What does comprehensive obesity care actually mean?

For many people, obesity treatment is often reduced to a single intervention, whether that's a diet, an obesity management medication (OMM), or metabolic & bariatric surgery. But effective obesity care is much more than any one treatment. It is a personalized, evidence-based approach that combines medical care, nutrition, physical activity, behavioral health, sleep, medications, surgery when appropriate, and long-term follow-up to support lifelong health.

In this episode of Weight & Measure with Mike and Zach, we're joined by Dr. Carolynn Francavilla, MD, MFOMA, DABOM, the 2025 Obesity Medicine Association Clinician of the Year, and Dr. Rebecca Andrick, DO, DABOM, FOMA, two leading obesity medicine specialists who are helping redefine what patient-centered obesity care should look like.

Together, we answer one of the most important questions facing patients today:

Do you have comprehensive obesity care?

We explore why obesity is recognized as a chronic disease, how obesity medicine has evolved beyond "eat less and move more," and why long-term success often requires multiple evidence-based tools working together. We also discuss where obesity management medications (OMMs), including GLP-1 and GLP/GIP therapies, fit into treatment, how metabolic & bariatric surgery complements medical care, and why individualized treatment plans lead to better patient outcomes.

Whether you're living with obesity, considering treatment options, supporting a loved one, or working in healthcare, this conversation will help you better understand what high-quality, comprehensive obesity care should include and what every patient deserves from their healthcare team.

• What comprehensive obesity care really means
• Why obesity is a chronic disease, not a personal failure
• How obesity medicine has evolved beyond "eat less and move more"
• Where obesity management medications (OMMs), including GLP-1 and GLP/GIP therapies, fit into treatment
• The role of metabolic & bariatric surgery in comprehensive obesity care
• Why multidisciplinary care leads to better long-term outcomes
• Nutrition, physical activity, sleep, and behavioral health as essential parts of treatment
• How patients can advocate for evidence-based obesity care
• Weight bias, stigma, and improving the patient experience
• Measuring success beyond the number on the scale
• The future of obesity medicine and comprehensive obesity care

Dr. Carolynn Francavilla, MD, MFOMA, DABOM
Board-Certified Family Physician
2025 Obesity Medicine Association Clinician of the Year

Dr. Rebecca Andrick, DO, DABOM, FOMA
Board-Certified Obesity Medicine Physician
Fellow of the Obesity Medicine Association

Mike Donnelly-Boylen
Zachary Niemiec, MBA

🎧 Subscribe to Weight & Measure

Follow Weight & Measure on your favorite podcast platform for conversations with leading physicians, researchers, registered dietitians, patient advocates, and individuals with lived experience as we explore the science of obesity, obesity medicine, GLP-1 medications, metabolic & bariatric surgery, nutrition, advocacy, and long-term obesity care.

Spotify:
https://open.spotify.com/show/45vJYXZC0ciTNpfwoc9CVI?si=HicpBPlwQEWD9RhM3t8BjA

Apple Podcasts:
https://podcasts.apple.com/us/podcast/weight-measure/id1886848263

Amazon Music:
https://music.amazon.com/podcasts/183597e3-d4de-4d93-a7c0-55f0cc6018bd/weight-measure?ref=dm_sh_iwSFqgfpShmLX8vRQR2ZxyJ5y

If you enjoyed this episode, please subscribe, leave a rating and review, and share it with someone who could benefit from learning more about comprehensive obesity care.

#Obesity #ObesityMedicine #ComprehensiveObesityCare #GLP1 #GLPGIP #ObesityTreatment #MetabolicBariatricSurgery #WeightManagement #PatientAdvocacy #WeightAndMeasure